Molecular and Clinical Links between Drug-Induced Cholestasis and Familial Intrahepatic Cholestasis
Idiosyncratic Drug-Induced Liver Injury (iDILI) represents an actual health challenge, accounting for more than 40% of hepatitis cases in adults over 50 years and more than 50% of acute fulminant hepatic failure cases. In addition, approximately 30% of iDILI are cholestatic (drug-induced cholestasis...
Main Authors: | Giovanni Vitale, Alessandro Mattiaccio, Amalia Conti, Sonia Berardi, Vittoria Vero, Laura Turco, Marco Seri, Maria Cristina Morelli |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-03-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/6/5823 |
Similar Items
-
A Complex Case of Cholestasis in a Patient with ABCB4 and ABCB11 Mutations
by: Mariana Ferreira Cardoso, et al.
Published: (2017-11-01) -
Case series of progressive familial intrahepatic cholestasis type 3: Characterization of variants in ABCB4 in China
by: Jinlin Cheng, et al.
Published: (2022-12-01) -
In vitro functional rescue by ivacaftor of an ABCB11 variant involved in PFIC2 and intrahepatic cholestasis of pregnancy
by: Elodie Mareux, et al.
Published: (2021-11-01) -
Drug-induced cholestasis: causative agents and challenges in diagnosis and management
by: Jose M. Pinazo-Bandera, et al.
Published: (2023-09-01) -
Genetics in Familial Intrahepatic Cholestasis: Clinical Patterns and Development of Liver and Biliary Cancers: A Review of the Literature
by: Giovanni Vitale, et al.
Published: (2022-07-01)